Related Experiment Video

Updated: Jul 20, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Combining evidence and diffusion of innovation theory to enhance influenza immunization

Maria T Britto1, Geralyn M Pandzik, Connie S Meeks

  • 1Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, USA. maria.britto@cchmc.org

Joint Commission Journal on Quality and Patient Safety
|September 8, 2006
PubMed

Insights

Implementing a multi-strategy approach based on diffusion of innovation theory significantly boosted influenza immunization rates in pediatric patients with chronic conditions, achieving higher success than previously reported.

Area of Science:

  • Pediatric Healthcare
  • Public Health Interventions
  • Infectious Disease Prevention

Background:

  • Children and adolescents with chronic conditions face high influenza risks.
  • Annual influenza immunization is recommended for these vulnerable populations.
  • Cystic Fibrosis (CF) patients at Cincinnati Children's achieved a 90.4% immunization rate.

Purpose of the Study:

  • To implement and evaluate a multi-faceted intervention strategy to increase influenza immunization rates.
  • To apply diffusion of innovation theory to spread successful immunization practices across clinics.
  • To improve vaccination coverage in pediatric patients with chronic health conditions.

Main Methods:

  • Utilized nurse-led teams, collaborative learning, and a comprehensive toolkit.
  • Implemented open-access scheduling, standing orders, and a web-based registry.
  • Employed facilitated vaccine ordering, recall phone calls, and weekly results posting.

Main Results:

  • Overall immunization rate reached 60.0% (762/1,269) across participating clinics.
  • Clinic-specific rates varied from 32.7% to 92.8%, with the highest in the CF clinic.
  • Barriers included vaccine shortages, time constraints for reminders, and physician support issues.

Conclusions:

  • A combination of evidence-based interventions, guided by diffusion of innovation theory, effectively increased immunization rates.
  • The study demonstrated successful spread of an intervention to improve influenza vaccination in high-risk pediatric populations.
  • Findings suggest this model can be adapted to enhance immunization coverage in similar clinical settings.
Abstract

More Related Videos

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null hypothesis and 'fail to...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...